By-Health
By-Health Co. produces and sells nutritional and dietary supplements primarily in China.
Launch date
Employees
Market cap
AUD3.9b
Enterprise valuation
AUD3.3b (Public information from Sep 2024)
Share price
CNY11.03 300146.SZ
Guangzhou Guangdong (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 6.1b | 7.4b | 7.9b | 9.4b | 8.3b | 9.3b | 10.2b |
| % growth | 16 % | 22 % | 6 % | 20 % | (12 %) | 12 % | 9 % |
| EBITDA | 1.8b | 2.4b | 2.2b | 2.4b | 1.5b | 1.9b | 2.2b |
| % EBITDA margin | 29 % | 32 % | 28 % | 26 % | 18 % | 20 % | 22 % |
| Profit | 1.5b | 1.8b | 1.4b | 1.7b | 1.2b | 1.5b | 1.7b |
| % profit margin | 25 % | 24 % | 18 % | 19 % | 14 % | 16 % | 17 % |
| EV / revenue | 6.0x | 5.8x | 4.6x | 3.1x | 2.0x | 1.8x | 1.6x |
| EV / EBITDA | 20.9x | 17.8x | 16.6x | 12.0x | 11.4x | 9.2x | 7.5x |
| R&D budget | 140m | 150m | 158m | 179m | - | - | - |
| R&D % of revenue | 2 % | 2 % | 2 % | 2 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
